Kazakh version of the beck depression inventory: Validation study in female cancer patients
- PMID: 37519682
- PMCID: PMC10372230
- DOI: 10.1016/j.heliyon.2023.e18146
Kazakh version of the beck depression inventory: Validation study in female cancer patients
Abstract
This study aimed to evaluate the validity of the Beck Depression Inventory (BDI-II) as a screening tool for depression among Kazakh-speaking female cancer patients. A cross-sectional study design with random sampling was used to collect and analyze data from 115 female cancer patients. Means, sensitivity, specificity, and positive and negative predictive values were calculated. An analysis of receiver operating characteristic (ROC) curves was conducted to determine the optimal cut-off score for the BDI-II in this population as a screening tool for depression. Test-retest reliability and internal consistency were also tested. Results showed that using a BDI-II cut score of 15 retained high sensitivity (82.7%), increased specificity (75.0%), and improved positive (86.1%) and negative predictive values (69.8%) of the BDI-II compared to a cut score of 14. Kazakh BDI-II indicated excellent consistency (Cronbach's alpha of 0.86) and reliability (intraclass correlation coefficient (ICC) of 0.92 (95% CI [0.89-0.94])). The use of this valid screening tool can facilitate the diagnosis of depression in female cancer patients.
Keywords: BDI-II; Breast cancer; Population norms; Psychometric properties; Self-report questionnaire.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2022. Ca - Cancer J. Clin. 2022;72:7–33. - PubMed
-
- Brintzenhofe-Szoc K.M., Levin T.T., Li Y., Kissane D.W., Zabora J.R. Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics. 2009;50:383–391. - PubMed
-
- Wang Y.-H., Li J.-Q., Shi J.-F., Que J.-Y., Liu J.-J., Lappin J.M., Leung J., V Ravindran A., Chen W.-Q., Qiao Y.-L. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol. Psychiatr. 2020;25:1487–1499. - PubMed
-
- Kumar K.P.S., Srivastava S., Paswan S., Dutta A.S. Depression-symptoms, causes, medications and therapies. Pharma Innov. 2012;1:37.
LinkOut - more resources
Full Text Sources
